← AlphaSignal

AMGN

★★☆☆☆ Passtemplate

Amgen Inc.

Healthcare · sector percentile 92

Session move

$402.60

−$0.38-0.09%

Vol 0.63× avg

64/100 quant · tgt $390.94

RS60 +7.7% vs SPY · ADV$ 1255.6M

session 2026-10-06 · Snapshot — not live tape

Since last scan

2026-10-06 → 2026-10-07

Score+0.1Price−$0.38 · -0.09%Disclosure-8.0

Context only — not a buy/sell signal. Built from scan history and cached news/filings.

Snapshot quote

session 2026-10-06 · scan 2026-10-07 · pushed 10-07 13:51 ET · Regular session (stale)

Show quote fundamentals
Last (scan/close)
$402.60
Previous close
$402.98
Pushed last
$413.51 (stale) · 10-07 13:51 ET · Regular session
Session open
$403.30
Last session range
$396.01 – $405.00
52-week range
$281.86 – $447.03
Session volume
2,005,059
Avg volume (20d)
3,159,133
Market cap
$217.66B
PE (TTM)
25.01
Forward PE
16.45
Dividend yield
2.43%
1y target est.
$390.94
Next earnings
2026-11-03

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.

If you put $1,000.00 in

1y ago

$1,391.91

+39%

5y ago

$2,238.06

+124%

Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.

Market briefing

Curated digest — not a trade signal. Headlines and links as provided by the producer.

  • Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?

    On August 27, AstraZeneca PLC (NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) scored a shared clinical victory. Positive high-level results from the Phase III CROSSING trial showed that their co-developed severe asthma drug, TEZSPIRE, achieved statistically significant and clinically meaningful improvements across both co-primary endpoints, histologic remission and the frequency/severity of dysphagia, and all key secondary endpoints […]

    Yahoo · 2026-09-09

  • What Eli Lilly Was Telling You While It Rationed Its Own Launches

    Eli Lilly (LLY) stock has gained about 56% over the past year, moving from $722.65 to $1,123.91. Before that run the company was doing something strange. It was deliberately selling less medicine than people wanted to buy, and it kept saying so out loud.

    Yahoo · 2026-09-09

  • AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

    Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 24th Annual Global Healthcare Conference at 11:30 a.m. ET on Tuesday, September 15, 2026. Jay Bradner, executive vice president, Research and Development, Artificial Intelligence and Data at Amgen, and Thomas Dittrich, executive vice president and chief financial officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and th

    Yahoo · 2026-09-09

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

  • Bull Thesis — AMGN scores 64.45/100 (Pass) with revenue growth at 9.5% and a multi-factor profile supporting the current ranking.
  • Risks — Key risks for AMGN include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-11-03.
  • Target Upside — Consensus implied upside is -2.9%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.

Score History

2026-08-2764.5 pts · 2026-10-07

30 days of scans. Daily batch adds the next weekday automatically while the API is running.

  • DatePriceChgScoreRating
  • 2026-10-07$402.60−$0.3864.5Pass
  • 2026-10-06$402.98−$0.0664.3Pass
  • 2026-10-05$403.04−$4.2364.4Pass
  • 2026-10-02$407.27−$14.2463.9Pass
  • 2026-10-01$421.51−$2.1367.0Pass
  • 2026-09-30$423.64+$5.5167.1Pass
  • 2026-09-29$418.13+$3.5266.7Pass
  • 2026-09-28$414.61+$8.5766.6Pass
  • 2026-09-25$406.04−$0.0566.7Pass
  • 2026-09-24$406.09−$4.1567.4Pass
  • 2026-09-23$410.24+$17.0866.8Pass
  • 2026-09-22$393.16+$7.5166.8Pass
  • 2026-09-21$385.65+$5.8767.4Pass
  • 2026-09-18$379.78+$3.4366.8Pass
  • 2026-09-17$376.35+$0.7066.1Pass
  • 2026-09-16$375.65−$5.8565.3Pass
  • 2026-09-15$381.50+$4.1565.1Pass
  • 2026-09-14$377.35−$5.1265.1Pass
  • 2026-09-11$382.47−$8.8066.8Pass
  • 2026-09-10$391.27−$1.9067.3Pass
  • 2026-09-09$393.17−$44.0667.4Pass
  • 2026-09-08$437.23$0.0069.1Pass
  • 2026-09-07$437.23−$6.8969.1Pass
  • 2026-09-04$444.12+$1.2869.2Pass
  • 2026-09-03$442.84+$4.7269.2Pass
  • 2026-09-02$438.12+$8.2468.7Pass
  • 2026-09-01$429.88−$2.5469.5Pass
  • 2026-08-31$432.42−$4.5769.6Pass
  • 2026-08-28$436.99−$3.3569.0Pass
  • 2026-08-27$440.34—69.4Pass

Quant Breakdown

Revenue Growth
3.8
EPS Growth
16.0
ROE
12.0
PER Relative
6.6
Debt / Equity
0.0
FCF Margin
8.0
Analyst Upside
0.0
Insider / Sector
2.0
Momentum 3M
8.0
Earn. Surprise
8.0

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

as of 2026-10-06 · finra_cnms
Short / total
48.5%
vs 20d (z)
-0.44
Short vol
317,153
Status
ok

Squeeze pressure score

full

25/100

Short leg
10
Call leg
56
Activity
0.2
Call vol share
61.6%
PCR (vol)
0.62
Call OI share
48.8%
ATM IV
35.4%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

Disclosure score

Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.

No recent SEC filings or earnings calendar inputs in the score window yet.

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

Earnings surprise (quant context)

From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.

Last reported surprise +0.7%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-13·sec_edgar·CIK 0000318154
Next earnings
2026-11-03yahoo_calendar
Last earnings
—

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.